These codes are used to report injectable drugs that ordinarily cannot be self-administered; chemotherapy, immunosuppressive drugs and inhalation solutions as well as some orally administered drugs.


  • J0120

    Injection, tetracycline, up to 250 mg
  • J0121

    Injection, omadacycline, 1 mg
  • J0122

    Injection, eravacycline, 1 mg
  • J0129

    Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
  • J0130

    Injection abciximab, 10 mg
  • J0131

    Injection, acetaminophen, not otherwise specified,10 mg
  • J0132

    Injection, acetylcysteine, 100 mg
  • J0133

    Injection, acyclovir, 5 mg
  • J0134

    Injection, acetaminophen (fresenius kabi) not therapeutically equivalent to j0131, 10 mg
  • J0135

    Injection, adalimumab, 20 mg


  • Continued
  • J0136

    Injection, acetaminophen (b braun) not therapeutically equivalent to j0131, 10 mg
  • J0137

    Injection, acetaminophen (hikma) not therapeutically equivalent to j0131, 10 mg
  • J0150

    Injection, adenosine for therapeutic use, 6 mg (not to be used to report any adenosine phosphate compounds, instead use a9270)
  • J0151

    Injection, adenosine for diagnostic use, 1 mg (not to be used to report any adenosine phosphate compounds, instead use a9270)
  • J0153

    Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds)
  • J0171

    Injection, adrenalin, epinephrine, 0.1 mg
  • J0172

    Injection, aducanumab-avwa, 2 mg
  • J0173

    Injection, epinephrine (belcher) not therapeutically equivalent to j0171, 0.1 mg
  • J0174

    Injection, lecanemab-irmb, 1 mg
  • J0178

    Injection, aflibercept, 1 mg
  • J0179

    Injection, brolucizumab-dbll, 1 mg
  • J0180

    Injection, agalsidase beta, 1 mg
  • J0184

    Injection, amisulpride, 1 mg   New
  • J0185

    Injection, aprepitant, 1 mg
  • J0190

    Injection, biperiden lactate, per 5 mg
  • J0200

    Injection, alatrofloxacin mesylate, 100 mg
  • J0202

    Injection, alemtuzumab, 1 mg
  • J0205

    Injection, alglucerase, per 10 units
  • J0206

    Injection, allopurinol sodium, 1 mg
  • J0207

    Injection, amifostine, 500 mg


  • Continued
  • J0208

    Injection, sodium thiosulfate, 100 mg
  • J0210

    Injection, methyldopate hcl, up to 250 mg
  • J0215

    Injection, alefacept, 0.5 mg
  • J0216

    Injection, alfentanil hydrochloride, 500 micrograms
  • J0217

    Injection, velmanase alfa-tycv, 1 mg   New
  • J0218

    Injection, olipudase alfa-rpcp, 1 mg
  • J0219

    Injection, avalglucosidase alfa-ngpt, 4 mg
  • J0220

    Injection, alglucosidase alfa, 10 mg, not otherwise specified
  • J0221

    Injection, alglucosidase alfa, (lumizyme), 10 mg
  • J0222

    Injection, patisiran, 0.1 mg
  • J0223

    Injection, givosiran, 0.5 mg
  • J0224

    Injection, lumasiran, 0.5 mg
  • J0225

    Injection, vutrisiran, 1 mg
  • J0248

    Injection, remdesivir, 1 mg
  • J0256

    Injection, alpha 1 proteinase inhibitor (human), not otherwise specified, 10 mg
  • J0257

    Injection, alpha 1 proteinase inhibitor (human), (glassia), 10 mg
  • J0270

    Injection, alprostadil, 1.25 mcg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
  • J0275

    Alprostadil urethral suppository (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
  • J0278

    Injection, amikacin sulfate, 100 mg
  • J0280

    Injection, aminophyllin, up to 250 mg